New cancer clinical trial: Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Published on: April 06, 2018 at 12:00PM
Conditions:   Advanced Solid Tumors;   Pancreatic Cancer;   Non Small Cell Lung Cancer;   Ovarian Cancer
Intervention:   Biological: MSC-1
Sponsor:   Northern Biologics Inc.
Not yet recruiting
https://ift.tt/2GFiiVz